Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.

Roles of all-trans-retinoic acid (tRA), a metabolite of vitamin A (VA), in both tolerogenic and immunogenic responses are documented. However, how tRA affects the development of systemic autoimmunity is poorly understood. Here we demonstrate that tRA have paradoxical effects on the development of au...

Full description

Bibliographic Details
Main Authors: Xiaofeng Liao, Jingjing Ren, Cheng-Hsin Wei, A Catharine Ross, Thomas E Cecere, Bernard S Jortner, S Ansar Ahmed, Xin M Luo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4361690?pdf=render
_version_ 1818425963922325504
author Xiaofeng Liao
Jingjing Ren
Cheng-Hsin Wei
A Catharine Ross
Thomas E Cecere
Bernard S Jortner
S Ansar Ahmed
Xin M Luo
author_facet Xiaofeng Liao
Jingjing Ren
Cheng-Hsin Wei
A Catharine Ross
Thomas E Cecere
Bernard S Jortner
S Ansar Ahmed
Xin M Luo
author_sort Xiaofeng Liao
collection DOAJ
description Roles of all-trans-retinoic acid (tRA), a metabolite of vitamin A (VA), in both tolerogenic and immunogenic responses are documented. However, how tRA affects the development of systemic autoimmunity is poorly understood. Here we demonstrate that tRA have paradoxical effects on the development of autoimmune lupus in the MRL/lpr mouse model. We administered, orally, tRA or VA mixed with 10% of tRA (referred to as VARA) to female mice starting from 6 weeks of age. At this age, the mice do not exhibit overt clinical signs of lupus. However, the immunogenic environment preceding disease onset has been established as evidenced by an increase of total IgM/IgG in the plasma and expansion of lymphocytes and dendritic cells in secondary lymphoid organs. After 8 weeks of tRA, but not VARA treatment, significantly higher pathological scores in the skin, brain and lung were observed. These were accompanied by a marked increase in B-cell responses that included autoantibody production and enhanced expression of plasma cell-promoting cytokines. Paradoxically, the number of lymphocytes in the mesenteric lymph node decreased with tRA that led to significantly reduced lymphadenopathy. In addition, tRA differentially affected renal pathology, increasing leukocyte infiltration of renal tubulointerstitium while restoring the size of glomeruli in the kidney cortex. In contrast, minimal induction of inflammation with tRA in the absence of an immunogenic environment in the control mice was observed. Altogether, our results suggest that under a predisposed immunogenic environment in autoimmune lupus, tRA may decrease inflammation in some organs while generating more severe disease in others.
first_indexed 2024-12-14T14:22:18Z
format Article
id doaj.art-ba77d0cca0be4babb980e289c9891b11
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-14T14:22:18Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-ba77d0cca0be4babb980e289c9891b112022-12-21T22:58:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01103e011817610.1371/journal.pone.0118176Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.Xiaofeng LiaoJingjing RenCheng-Hsin WeiA Catharine RossThomas E CecereBernard S JortnerS Ansar AhmedXin M LuoRoles of all-trans-retinoic acid (tRA), a metabolite of vitamin A (VA), in both tolerogenic and immunogenic responses are documented. However, how tRA affects the development of systemic autoimmunity is poorly understood. Here we demonstrate that tRA have paradoxical effects on the development of autoimmune lupus in the MRL/lpr mouse model. We administered, orally, tRA or VA mixed with 10% of tRA (referred to as VARA) to female mice starting from 6 weeks of age. At this age, the mice do not exhibit overt clinical signs of lupus. However, the immunogenic environment preceding disease onset has been established as evidenced by an increase of total IgM/IgG in the plasma and expansion of lymphocytes and dendritic cells in secondary lymphoid organs. After 8 weeks of tRA, but not VARA treatment, significantly higher pathological scores in the skin, brain and lung were observed. These were accompanied by a marked increase in B-cell responses that included autoantibody production and enhanced expression of plasma cell-promoting cytokines. Paradoxically, the number of lymphocytes in the mesenteric lymph node decreased with tRA that led to significantly reduced lymphadenopathy. In addition, tRA differentially affected renal pathology, increasing leukocyte infiltration of renal tubulointerstitium while restoring the size of glomeruli in the kidney cortex. In contrast, minimal induction of inflammation with tRA in the absence of an immunogenic environment in the control mice was observed. Altogether, our results suggest that under a predisposed immunogenic environment in autoimmune lupus, tRA may decrease inflammation in some organs while generating more severe disease in others.http://europepmc.org/articles/PMC4361690?pdf=render
spellingShingle Xiaofeng Liao
Jingjing Ren
Cheng-Hsin Wei
A Catharine Ross
Thomas E Cecere
Bernard S Jortner
S Ansar Ahmed
Xin M Luo
Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
PLoS ONE
title Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
title_full Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
title_fullStr Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
title_full_unstemmed Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
title_short Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.
title_sort paradoxical effects of all trans retinoic acid on lupus like disease in the mrl lpr mouse model
url http://europepmc.org/articles/PMC4361690?pdf=render
work_keys_str_mv AT xiaofengliao paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT jingjingren paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT chenghsinwei paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT acatharineross paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT thomasececere paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT bernardsjortner paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT sansarahmed paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel
AT xinmluo paradoxicaleffectsofalltransretinoicacidonlupuslikediseaseinthemrllprmousemodel